Literature DB >> 11704679

Cell surface-localized nucleolin is a eukaryotic receptor for the adhesin intimin-gamma of enterohemorrhagic Escherichia coli O157:H7.

James F Sinclair1, Alison D O'Brien.   

Abstract

Intimin-gamma is an outer membrane protein of enterohemorrhagic Escherichia coli (EHEC) O157:H7 that is required for the organism to adhere tightly to HEp-2 cells and to colonize experimental animals. Another EHEC O157:H7 protein, the Transferred intimin receptor (Tir), is considered the primary receptor for intimin-gamma. Nevertheless, Tir-independent binding of intimin-gamma to HEp-2 cells has been reported. This observation suggests the existence of a eukaryotic receptor(s) for intimin-gamma. In this study, we sought to identify that receptor(s). First, we determined by equilibrium binding titration that the association of purified intimin-gamma with HEp-2 cells was specific and consistent with a single host cell receptor. Second, we isolated a protein from lysates of HEp-2 cells that bound intimin-gamma and subsequently identified this molecule as nucleolin, a protein involved in cell growth regulation that can be cell surface-expressed. Third, we established that purified intimin-gamma and nucleolin were co-localized on the surface of HEp-2 cells and that the site of EHEC O157:H7 attachment was associated with regions of nucleolin expression. Finally, we demonstrated that mouse anti-nucleolin sera significantly decreased the adherence of EHEC O157:H7 to HEp-2 cells. From this, we conclude that nucleolin is the HEp-2 cell receptor for intimin-gamma expressed by EHEC O157:H7.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11704679     DOI: 10.1074/jbc.M110230200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  73 in total

1.  Binding of intimin from enteropathogenic Escherichia coli to lymphocytes and its functional consequences.

Authors:  Nathalie S Gonçalves; Christine Hale; Gordon Dougan; Gad Frankel; Thomas T MacDonald
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

2.  Disruption of cell polarity by enteropathogenic Escherichia coli enables basolateral membrane proteins to migrate apically and to potentiate physiological consequences.

Authors:  Michelle M Muza-Moons; Athanasia Koutsouris; Gail Hecht
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

Review 3.  Molecular mechanisms that mediate colonization of Shiga toxin-producing Escherichia coli strains.

Authors:  Mauricio J Farfan; Alfredo G Torres
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

4.  Interaction of enteropathogenic and Shiga toxin-producing Escherichia coli and porcine intestinal mucosa: role of intimin and Tir in adherence.

Authors:  Francis Girard; Isabelle Batisson; Gad M Frankel; Josée Harel; John M Fairbrother
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 5.  Adherence of diarrheagenic Escherichia coli strains to epithelial cells.

Authors:  Alfredo G Torres; Xin Zhou; James B Kaper
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

6.  Interaction of enteropathogenic Escherichia coli with human intestinal mucosa: role of effector proteins in brush border remodeling and formation of attaching and effacing lesions.

Authors:  Robert K Shaw; Jennifer Cleary; Michael S Murphy; Gad Frankel; Stuart Knutton
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

7.  Use of in vivo-induced antigen technology for identification of Escherichia coli O157:H7 proteins expressed during human infection.

Authors:  Manohar John; Indira T Kudva; Robert W Griffin; Allen W Dodson; Bethany McManus; Bryan Krastins; David Sarracino; Ann Progulske-Fox; Jeffrey D Hillman; Martin Handfield; Phillip I Tarr; Stephen B Calderwood
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

Review 8.  Enteropathogenic and enterohemorrhagic Escherichia coli infections: translocation, translocation, translocation.

Authors:  Junkal Garmendia; Gad Frankel; Valérie F Crepin
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

9.  Plant cell-based intimin vaccine given orally to mice primed with intimin reduces time of Escherichia coli O157:H7 shedding in feces.

Authors:  Nicole A Judge; Hugh S Mason; Alison D O'Brien
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

10.  Role of nucleolin in human parainfluenza virus type 3 infection of human lung epithelial cells.

Authors:  Santanu Bose; Mausumi Basu; Amiya K Banerjee
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.